Patient perspectives on nipple-areola complex micropigmentation during the COVID-19 pandemic
Frost, Stephen Pilley, Matthew Porter, C Agarwal, Reena
Frost, Stephen
Pilley, Matthew
Porter, C
Agarwal, Reena
Abstract
Background: Micropigmentation is a well-recognised option for nipple-areola complex reconstruction, as part of the breast reconstruction pathway for patients following mastectomy. As a part of delayed breast reconstruction, this treatment was put on hold during the COVID-19 pandemic.
Aims: To assess the views of patients regarding micropigmentation in response to the COVID-19 pandemic, and whether their attitudes to seeking out this part of the reconstructive journey had been altered.
Methods: A questionnaire undertaken with 53 patients between August & September 2020 attending the Micropigmentation clinic.
Findings: 81.1% of patients reported COVID-19 had not impacted their decision, with a similar proportion happy to proceed with the treatment at the time of questioning.
Conclusions: The results highlight the importance of nipple-areola complex to our patients' reconstructive journey.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2022-06-23
Type
Article
Collections
Citation
Frost, S., Pilley, M., Porter, C., & Agarwal, R. (2022). Patient perspectives on nipple-areola complex micropigmentation during the COVID-19 pandemic. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 75(8), 2831–2870. https://doi.org/10.1016/j.bjps.2022.06.032